• U0126 for Reliable MEK1/2 Assays

  2026-08-14

  A practical, scenario-based guide to using U0126 (SKU BA2003) in viability, proliferation, and cytotoxicity workflows. It connects MEK1/2 inhibition with assay compatibility, dosing, storage, interpretation, and vendor-selection decisions.

• Neurotensin: An Assay-First GPCR Roadmap

  2026-08-14

  Neurotensin is a precise Neurotensin receptor 1 activator for connecting acute GPCR signaling with receptor recycling and miR-133α modulation. This assay-first guide combines peptide handling, layered gastrointestinal readouts, and lessons from fluorescence-classification research to improve experimental interpretation.

• X-Gal: Mechanism and Blue-White Screening

  2026-08-13

  X-Gal, also called 5-bromo-4-chloro-indolyl-β-D-galactopyranoside, is a chromogenic β-galactosidase substrate used to distinguish recombinant clones. Its lacZ-dependent blue-white colony screening readout is visual, rapid, and best treated as a screening result that requires molecular confirmation.

• Melatonin, RIPK3, and Atrazine Kidney Injury

  2026-08-13

  This study identifies RIPK3-dependent necroptosis as a central mechanism of atrazine-induced renal tubular injury and shows that melatonin suppresses this pathway. Its combination of animal, cellular, genetic, and computational evidence provides a useful framework for studying chemical nephrotoxicity and testing mechanism-based interventions.

• Tetrahydromagnolol: From GPCR Bias to Cell Motility

  2026-08-12

  Tetrahydromagnolol is a selective peripheral CB2 receptor agonist with a complementary GPR55-antagonist profile. This article develops a mechanistic framework for connecting receptor pharmacology with cytoskeletal and motility assays, while defining which conclusions are established and which require validation.

• Standardized Whole-Blood Stimulation in Immunometabolism

  2026-08-12

  Zhao and colleagues present a standardized whole-blood stimulation protocol that combines defined immune challenges with metabolic pathway modulation and cytokine measurement. Its main contribution is methodological: it provides a reproducible framework for comparing immunometabolic responses across donors and experimental conditions while preserving the cellular and plasma context of whole blood.

• Tetrahydromagnolol: From CB2 Biology to Translation

  2026-08-11

  Tetrahydromagnolol offers translational researchers a selective pharmacology tool for connecting peripheral CB2 receptor signaling with rigorous pathway and phenotype studies. By placing its CB2 agonism and GPR55 antagonism alongside new evidence for GPCR-driven ERM activation in triple-negative breast cancer, this article defines a disciplined framework for mechanistic validation without overstating cross-domain evidence.

• Trametinib: A Pathway-Causal Assay Strategy

  2026-08-11

  Trametinib and GSK1120212 are powerful tools for connecting MEK-ERK target engagement with cell fate and endothelial phenotypes. This article develops a pathway-causal assay framework grounded in cancer biology and a murine lupus lung-injury study.

• Etomoxir for Fatty Acid Oxidation Research

  2026-08-10

  Etomoxir enables controlled fatty acid oxidation pathway research in whole-blood, cellular, and disease-model workflows. Its strongest use-case is metabolic perturbation paired with cytokine, lipid, and viability readouts, while dose-dependent DGAT activity requires careful interpretation.

• RNA Pol II Degradation and Transcription-Independent Death

  2026-08-09

  The preprint argues that RNA polymerase II degradation can activate regulated cell death through a mechanism distinct from transcriptional shutdown. Its central implication is that loss of the hypophosphorylated Pol II IIA pool may function as a death signal, providing a framework for separating transcriptional effects from cytotoxic signaling in mechanistic cancer research.

• GSK-923295 for CENP-E Mitotic Assays

  2026-08-08

  GSK-923295 provides a reversible, concentration-controlled way to induce CENP-E-dependent mitotic disruption and quantify chromosome-alignment defects. Its strongest use is as a mechanistic companion to rapid CTCF depletion, helping researchers distinguish motor-driven congression failure from broader centromere-architecture defects.

• ω-Agatoxin IVA and Excitotoxicity in Cortical Neurons

  2026-08-07

  Lustig, Ahern, and Greenberg tested whether blocking P/Q-type calcium channels with ω-agatoxin IVA could protect cultured cortical neurons from acute excitotoxic injury triggered by veratridine, ouabain, or NMDA. The antagonist failed to reduce LDH-defined toxicity at concentrations below 300 nM, showing that inhibition of presynaptic glutamate release does not necessarily prevent downstream neuronal injury.

• Nile Red (SKU B8209): Optimizing Lipid Droplet Assays in Cel

  2026-08-07

  This article delivers scenario-driven, evidence-based guidance for optimizing intracellular lipid droplet staining using Nile Red (SKU B8209). Drawing on validated workflows and recent literature, it addresses common laboratory challenges in lipid metabolism research and highlights the reliability and performance advantages of APExBIO's Nile Red.

• Bone Transport Promotes Diabetic Foot Healing via TGF-β1 Pat

  2026-08-06

  This study reveals that bone transport (BT) accelerates diabetic foot ulcer healing by activating the TGF-β1/TGFBR1 signaling axis, effectively coupling angiogenesis, osteogenesis, and immunomodulation. These findings clarify the molecular mechanisms underlying BT’s therapeutic effects and highlight TGF-β1 pathway modulation as a promising strategy for chronic wound repair.

• ETS1 Modulates SUMOylation-Dependent Mitophagy in BPD Models

  2026-08-06

  This study reveals that ETS1, a transcription factor, protects against bronchopulmonary dysplasia (BPD) by inhibiting mitochondrial damage-induced autophagy through the SENP2/HSPA8/FUNDC1 axis. By elucidating the mechanistic link between SUMOylation and mitophagy, the research provides a molecular basis for targeted interventions in neonatal lung disease.

15297 records 1/1020 page Next 12345 下5页 Last page